Samsung R20 Ultrasound System Launches at RSNA 2025: Advanced AI and Ergonomics

HIT Consultant – Read More

What You Should Know:

– Samsung Medison, a global medical equipment company and affiliate of Samsung Electronics unveils a major innovation in diagnostic imaging: the Samsung R20 Ultrasound System during the Radiological Society of North America (RSNA) 2025 Annual Meeting in Chicago, Illinois.

– The R20 represents a new era of ultrasound technology, leveraging advanced hardware and novel image formation techniques to deliver elevated diagnostic precision and powerful, AI-driven technologies. Crucially, it also introduces ergonomic innovations that have been independently validated to enhance user comfort and scanning efficiency.

Addressing Today’s Healthcare Challenges

Modern ultrasound examinations face growing complexity. Rising rates of obesity and chronic disease often lead to more challenging cases, resulting in higher rates of inconclusive results and driving demand for technologies with deeper penetration and intelligent clinician support.

Simultaneously, the widespread issue of sonographer pain and persistent workforce shortages underscore the critical importance of ergonomic design. The R20 was engineered to meet these converging challenges head-on, combining imaging precision, Artificial Intelligence (AI), and optimal ergonomics in a single, comprehensive system.

Advanced Imaging Engine and AI Integration

Built for exceptional performance, the R20 is powered by Samsung’s Advanced Imaging Engine. This technology integrates cutting-edge hardware with sophisticated software beamforming to achieve remarkable image clarity and diagnostic accuracy, helping clinicians scan with greater confidence in complex cases.

The R20 offers more than a dozen AI-powered tools for:

Real-time exam guidance
Diagnostic assistance
Workflow automation
Automated measurements

These features are designed to help clinicians improve accuracy and save valuable time.

“The R20 embodies our mission to elevate diagnostic imaging through purposeful innovation,” said Tracy Bury, Chief Commercial Officer of Samsung Healthcare in the USA and Vice President of Global Growth Initiatives. “Driven by close collaboration with clinicians, the R20’s technologies are designed as practical tools that make a real difference in how clinicians work, and patients are cared for. With the R20, we’re moving from a fast follower to a true technology leader, driving innovation at a pace that’s reshaping ultrasound.”